Related Experiment Video
Updated: Sep 14, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
Risk of neuropsychiatric and related conditions associated with SARS-CoV-2 infection: a difference-in-differences
Yiwen Lu1,2, Jiayi Tong1,3,4, Dazheng Zhang1,3
1Center for Health AI and Synthesis of Evidence (CHASE), Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Insights
COVID-19 infection increases neuropsychiatric risks in children and youths. SARS-CoV-2 (the virus causing COVID-19) is linked to conditions like anxiety, ADHD, and depression, necessitating further research.
Area of Science:
- Neuroscience
- Pediatrics
- Infectious Diseases
Background:
- The COVID-19 pandemic has seen a rise in neuropsychiatric issues among young people.
- Emerging evidence suggests SARS-CoV-2 infection itself may pose risks beyond general pandemic stressors.
Purpose of the Study:
- To evaluate the spectrum of neuropsychiatric conditions in children and youths post-SARS-CoV-2 infection.
- To compare outcomes between COVID-19 positive and negative pediatric cohorts, controlling for infection risk factors.
Main Methods:
- Retrospective analysis of electronic health records from 326,074 COVID-19 positive and 887,314 negative participants (ages 5-20) in the RECOVER program.
- Matching participants based on risk factors and stratifying by age.
- Examining neuropsychiatric outcomes 28–179 days post-infection/negative test (March 2020–December 2022).
Main Results:
- COVID-19 positive children (5-12) showed increased risks for anxiety, OCD, ADHD, and autism.
- COVID-19 positive youths (12-20) had elevated risks for anxiety, suicidality, depression, and related symptoms.
- Higher frequencies of neuropsychiatric conditions were observed in the SARS-CoV-2 positive cohort.
Conclusions:
- SARS-CoV-2 infection may be a contributing factor to neuropsychiatric conditions in children and youths.
- Findings underscore the need for research into targeted treatments and prevention strategies.
- This study highlights a significant association between COVID-19 and pediatric neuropsychiatric health.
Abstract:
The COVID-19 pandemic has been associated with increased neuropsychiatric conditions in children and youths, with evidence suggesting that SARS-CoV-2 infection may contribute additional risks beyond pandemic stressors. This study aims to assess the full spectrum of neuropsychiatric conditions in COVID-19 positive children (ages 5-12) and youths (ages 12-20) compared to a matched COVID-19 negative cohort, accounting for factors influencing infection risk. Using EHR data from 25 institutions in the RECOVER program, we conduct a retrospective analysis of 326,074 COVID-19 positive and 887,314 negative participants matched for risk factors and stratified by age. Neuropsychiatric outcomes are examined 28 to 179 days post-infection or negative test between March 2020 and December 2022. SARS-CoV-2 positivity is confirmed via PCR, serology, or antigen tests, while negativity requires negative test results and no related diagnoses. Risk differences reveal higher frequencies of neuropsychiatric conditions in the COVID-19 positive cohort. Children face increased risks for anxiety, OCD, ADHD, autism, and other conditions, while youths exhibit elevated risks for anxiety, suicidality, depression, and related symptoms. These findings highlight SARS-CoV-2 infection as a potential contributor to neuropsychiatric risks, emphasizing the importance of research into tailored treatments and preventive strategies for affected individuals.
Related Concept Videos
Bias in Epidemiological Studies
Confounding in Epidemiological Studies
Relative Risk
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Statistical Methods for Analyzing Epidemiological Data
Single Nucleotide Polymorphisms-SNPs

